Immunome up as antibody cocktail shows promise against Omicron subvariants

Immunome

06/07/2022 15:27

** Shares of drug developer Immunome  IMNM.O  rise 2% to
$3.49 
    ** Co says its experimental antibody cocktail, IMM-BCP-01,
retained activity against Omicron BA.4/5 and BA.2.12.1
subvariants in pseudovirus testing  urn:newsml:reuters.com:*:nBwc54VPha
    ** IMM-BCP-01 is currently in early-stage testing in
patients infected with SARS-CoV-2 and in locations where these
subvariants are predominant
    ** As of July 2, BA.4 and BA.5 are estimated to make up a
combined 70.1% of coronavirus variants in U.S.  urn:newsml:reuters.com:*:nL4N2YM2ZW
    ** Stock down ~73% YTD 

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com;))